UniSC Clinical Trials is a university based multi-site clinical trial network specialising in delivering high-quality and efficient vaccine studies, from first-in-human through to late phase trials.
Our expertise spans an expanding portfolio of vaccine platforms such as mRNA, viral vectors, whole virus, GMO, protein subunit, virus-like particles, and combination vaccines. Our experience extends to testing various novel delivery methods, including intranasal, intramuscular, and micro-array patch administration.
We collaborate with pharmaceutical and biotechnology companies to support their development by conducting both high-volume trials and specialised, complex studies, whilst improving access to innovative research within our community.
Our dedicated team of over 140 professionals guide clinical trials from inception to completion, ensuring regulatory compliance and ethical standards. We routinely exceed recruitment targets through patient focused outreach strategies, managing timelines, risks, and budgets to set the stage for successful, quality research and seamless execution.